Loading clinical trials...
Loading clinical trials...
This is a prospective, single-arm study in adults with recurrent or metastatic clear cell renal cell carcinoma (ccRCC). Participants will receive standard systemic therapy (targeted therapy plus anti-...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Peking University First Hospital
NCT07324577 · Radiation Therapy, Virtual Reality
NCT02986048 · Treatment With Proton Beam Radiation Therapy
NCT07123090 · Metastatic Renal Cell Carcinoma, Metastatic Renal Cancer, and more
NCT07426094 · Prostate Cancer, Brachytherapy, and more
NCT06987890 · Lung Cancer (NSCLC), Geriatric Assessment, and more
Peking University First Hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions